Incidence of Fungal Pneumonia in Children with Acute Myeloid Leukemia Taking Oral Antifungal Prophylaxis: Fungal Pneumonia with Acute Myeloid Leukemia Taking Oral Antifungal Prophylaxis

Luqman Iqbal; Shazia Riaz; Sana Gull; Irsa Iqbal; Aimen Gull; Toqeer Ahmed

doi:10.54393/pjhs.v6i7.3143

Authors

Luqman Iqbal Department of Pediatric Oncology, University of Child Health Sciences, The Children's Hospital, Lahore, Pakistan
Shazia Riaz Department of Pediatric Oncology, University of Child Health Sciences, The Children's Hospital, Lahore, Pakistan
Sana Gull Department of Pediatric Oncology, University of Child Health Sciences, The Children's Hospital, Lahore, Pakistan
Irsa Iqbal Department of Pediatric Oncology, University of Child Health Sciences, The Children's Hospital, Lahore, Pakistan
Aimen Gull Department of Pediatric Oncology, University of Child Health Sciences, The Children's Hospital, Lahore, Pakistan
Toqeer Ahmed Department of Pediatric Oncology, University of Child Health Sciences, The Children's Hospital, Lahore, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v6i7.3143

Keywords:

Acute Myeloid Leukemia, Fungal Pneumonia, Invasive Fungal Disease, Antifungal Prophylaxis, Voriconazole, Posaconazole

Abstract

Acute leukemia is common in children, with acute lymphoblastic leukemia (ALL) making up 80-85% and acute myeloid leukemia (AML) 10-15%. Objective: To determine the incidence of fungal pneumonia in children with acute myeloid leukemia taking oral antifungal prophylaxis. Methods: In this single-center retrospective study done in a tertiary care hospital, the study analyzed 276 pediatric AML cases from July 2022 to June 2024. The diagnosis of fungal pneumonia was made on the basis of CT scan findings. Demographic and AML subtype data were also analyzed. Results: Among the 276 AML patients enrolled in this study, the mean age of the patients was 8.4 years (range 1-16 years), and there was a male predominance (157 male vs. 119 female). The most common AML subtype was M2 (34.1%), followed by M4 (16.7%) and M5 (8.3%). Out of 276 patients with AML, 69 (25.0%) had CT findings suggestive of fungal pneumonia. M2 and M4 subtypes were the most commonly affected, accounting for about 50% of cases. Conclusions: Children with AML taking oral primary antifungal prophylaxis have a 25% incidence of fungal pneumonia. These findings highlight the importance of vigilant imaging surveillance and targeted interventions in high-risk subgroups (M2 and M4).

References

Rubnitz JE and Kaspers GJ. How I Treat Pediatric Acute Myeloid Leukemia. Blood, The Journal of the American Society of Hematology. 2021 Sep; 138(12): 1009-18. doi: 10.1182/blood.2021011694.

Temple WC, Mueller S, Hermiston ML, Burkhardt B. Diagnosis and Management of Lymphoblastic Lymphoma in Children, Adolescents and Young Adults. Best Practice and Research Clinical Hematology. 2023 Mar; 36(1): 101449. doi: 10.1016/j.beha.2023.101449.

De Morais RV, De Souza MV, De Souza Silva KA, Santiago P, Lorenzoni MC, Lorea CF et al. Epidemiological Evaluation and Survival of Children with Acute Myeloid Leukemia. Jornal de Pediatria. 2021 Mar; 97(2): 204-10. doi: 10.1016/j.jped.2020.02.003.

Vakiti A, Reynolds SB, Mewawalla P. Acute Myeloid Leukemia. In Stat Pearls [internet]. 2024 Apr.

Chen J and Glasser CL. New and Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia (AML). Children. 2020 Feb; 7(2): 12. doi: 10.3390/children7020012.

Xu Q, Li H, Huang P, Lin W, Qi P, Wang L et al. Investigation of Infections Status in Pediatric Patients with Acute Myeloid Leukemia During the Induction Period–A Retrospective Study in Two Medical Centers. Annals of Hematology. 2024 Nov; 103(11): 4503-10. doi: 10.1007/s00277-024-05939-x.

Arad-Cohen N, Zeller B, Abrahamsson J, Fernandez Navarro JM, Cheuk D, Palmu S, Costa V et al. Supportive Care in Pediatric Acute Myeloid Leukemia: Expert-Based Recommendations of the NOPHO-DB-SHIP Consortium. Expert Review of Anticancer Therapy. 2022 Nov; 22(11): 1183-96. doi: 10.1080/14737140.2022.2131544.

Ávila Montiel D, Saucedo Campos A, Avilés Robles M, Murillo Maldonado MA, Jiménez Juárez R, Silva Dirzo M et al. Fungal Infections in Pediatric Patients with Acute Myeloid Leukemia in A Tertiary Hospital. Frontiers in Public Health. 2023 Mar; 11: 1056489. doi: 10.3389/fpubh.2023.1056489.

Oh SM, Byun JM, Chang E, Kang CK, Shin DY, Koh Y et al. Incidence of Invasive Fungal Infection in Acute Lymphoblastic and Acute Myelogenous Leukemia in the Era of Antimold Prophylaxis. Scientific Reports. 2021 Nov; 11(1): 22160. doi: 10.1038/s41598-021-01716-2.

Gal Etzioni TR, Fainshtain N, Nitzan-Luques A, Goldstein G, Weinreb S, Temper V et al. Invasive Fungal Infections in Children with Acute Leukemia: Epidemiology, Risk Factors, and Outcome. Microorganisms. 2024 Jan; 12(1): 145. doi: 10.3390/microorganisms12010145.

Gründahl M, Wacker B, Einsele H, Heinz WJ. Invasive Fungal Diseases in Patients with New Diagnosed Acute Lymphoblastic Leukaemia. Mycoses. 2020 Oct; 63(10): 1101-6. doi: 10.1111/myc.13151.

Lewis RE, Stanzani M, Morana G, Sassi C. Radiology-Based Diagnosis of Fungal Pulmonary Infections in High-Risk Hematology Patients: Are We Making Progress? Current Opinion in Infectious Diseases. 2023 Aug; 36(4): 250-6. doi: 10.1097/QCO.0000000000000937.

Lee SO. Diagnosis and Treatment of Invasive Mold Diseases. Infection and Chemotherapy. 2022 Nov; 55(1): 10. doi: 10.3947/ic.2022.0151.

Lehrnbecher T, Bochennek K, Groll AH. Mold-Active Antifungal Prophylaxis in Pediatric Patients with Cancer or Undergoing Hematopoietic Cell Transplantation. Journal of Fungi. 2023 Mar; 9(3): 387. doi: 10.3390/jof9030387.

Stemler J, Koehler P, Maurer C, Müller C, Cornely OA. Antifungal Prophylaxis and Novel Drugs in Acute Myeloid Leukemia: The Midostaurin and Posaconazole Dilemma. Annals of Hematology. 2020 Jul; 99(7): 1429-40. doi: 10.1007/s00277-020-04107-1.

Groll AH, Pana D, Lanternier F, Mesini A, Ammann RA, Averbuch D et al. 8th European Conference on Infections in Leukaemia: 2020 Guidelines for the Diagnosis, Prevention, and Treatment of Invasive Fungal Diseases in Paediatric Patients with Cancer or Post-Haematopoietic Cell Transplantation. The Lancet Oncology. 2021 Jun; 22(6): e254-69. doi: 10.1016/S1470-2045(20)30723-3.

Al Hajri H, Al-Salmi W, Al Hinai K, Al-Housni S, Al-Harrasi A, Al Hashami H et al. Invasive Fungal Infections in Children with Leukemia in A Tertiary Hospital in Oman: An Eight-Year Review. Current Medical Mycology. 2023 Sep; 9(3): 16. doi: 10.22034/CMM.2023.345108.1447.

Kobayashi R, Kaneda M, Sato T, Ichikawa M, Suzuki D, Ariga T. The Clinical Feature of Invasive Fungal Infection in Pediatric Patients with Hematologic and Malignant Diseases: A 10-Year Analysis at a Single Institution at Japan. Journal of Pediatric Hematology/Oncology. 2008 Dec; 30(12): 886-90. doi: 10.1097/MPH.0b013e3181864a80.

Fisher BT, Robinson PD, Lehrnbecher T, Steinbach WJ, Zaoutis TE, Phillips B et al. Risk Factors for Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review. Journal of the Pediatric Infectious Diseases Society. 2018 Sep; 7(3): 191-8. doi: 10.1093/jpids/pix030.

Sung LilLian SL, Lange BJ, Gerbing RB, Alonzo TA, Feusner J. Microbiologically Documented Infections and Infection-Related Mortality in Children with Acute Myeloid Leukemia. Blood. 2007 Nov; 110(10): 3532–3539. doi: 10.1182/blood-2007-05-091942.

Lehrnbecher T, Varwig D, Kaiser J, Reinhardt D, Klingebiel T, Creutzig U. Infectious Complications in Pediatric Acute Myeloid Leukemia: Analysis of the Prospective Multi-Institutional Clinical Trial AML-BFM 93. Leukemia. 2004 Jan; 18(1): 72-7. doi: 10.1038/sj.leu.2403188.

Greene RE, Schlamm HT, Oestmann JW, Stark P, Durand C, Lortholary O et al. Imaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo Sign. Clinical Infectious Diseases. 2007 Feb; 44(3): 373-9. doi: 10.1086/509917.

Castagnola E, Cesaro S, Giacchino M, Livadiotti S, Tucci F, Zanazzo G et al. Fungal Infections in Children with Cancer: A Prospective, Multicenter Surveillance Study. The Pediatric Infectious Disease Journal. 2006 Jul; 25(7): 634-9. doi: 10.1097/01.inf.0000220256.69385.2e.

Hovi L, Saarinen-Pihkala UM, Vettenranta K, Saxen H. Invasive Fungal Infections in Pediatric Bone Marrow Transplant Recipients: Single Center Experience of 10 Years. Bone Marrow Transplantation. 2000 Nov; 26(9): 999-1004. doi: 10.1038/sj.bmt.1702654.

Maertens JA, Girmenia C, Brüggemann RJ, Duarte RF, Kibbler CC, Ljungman P et al. European Guidelines for Primary Antifungal Prophylaxis in Adult Haematology Patients: Summary of the Updated Recommendations from the European Conference on Infections in Leukaemia. Journal of Antimicrobial Chemotherapy. 2018 Dec; 73(12): 3221-30. doi: 10.1093/jac/dky286.